Weil is advising CVC Catalyst II, CVC’s dedicated mid-market private equity strategy, in its agreement to acquire a majority stake in WillowWood Holdings Inc., a leading manufacturer of prosthetic products. CVC Catalyst will become the majority investor alongside Blue Sea Capital, the Arbogast family and Management.

CVC Catalyst plans to accelerate WillowWood’s next phase of growth. The partnership will invest in research and development and new product innovation, and will pursue an active M&A strategy to broaden the Company’s offering and geographic reach.

The Weil team is led by Private Equity partner Gareth Clark and includes associates Anna Gamayunov, Erin Richard, Tanner Woods, Akram Alhoribi and Sébastien He; Banking & Finance partner Paul Overmyer and associates Casper Lu and Hyemi Park (Not Yet Admitted in New York); Executive Compensation & Benefits partner Victoria Rosamond and associate Rustin Armknecht; Mergers & Acquisitions counsel Barrett Schitka; Technology & IP Transactions partners Karen Ballack and Liza Cotter and associates Chika Amene and Ashley Tanaka; Regulatory Transactions partners John O’Loughlin, Ariel Fliman, Antonia Tzinova and Matthew Morton and associates Christina Carone, Sisi Liu and Graham McHenry; Tax partner Jason Vollbracht and associate Griffin Baker; Employment partner Xander Tabloff and associate Paige Mickel; and Real Estate attorney Leslie Smith.